Turnaround story: Opyl’s new look

The eHealth technology company was a company with great tech and too many ideas, now it’s a business with great tech and one sharply defined purpose.

CEO Michelle Gallaher says Opyl’s decision support technology will not only vastly widen the pool of people open to participating in clinical trials improving recruitment numbers and speed, but also save the companies running studies millions of dollars by using AI to optimise the most-likely-to-succeed trial design .

This is only an excerpt. The original article was written by Stockhead and can be found here.